Platinum Corporate Members
AbbVie
AbbVie is a global, research-based biopharmaceutical company which combines the focus of a leading-edge biotech with the expertise and structure of a long-established pharmaceutical leader. AbbVie is committed to using unique approaches to innovation to develop and market advanced therapies that address some of the world’s most complex and serious diseases.
Amgen
At Amgen, we believe in a “biology first” approach. We use cutting-edge science and technology to study the subtlest biological mechanisms in search of therapies that will improve the lives of those who suffer from serious diseases. Amgen believes the cure for disease can be found inside each and every one of us.
Bristol-Myers Squibb
Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. We are a differentiated company, led by our unique BioPharma strategy that leverages the reach and resources of a major pharma company paired with the entrepreneurial spirit and agility of a biotech firm.
Celgene
At Celgene, we seek to deliver truly innovative and life-changing drugs for our patients. Our vision as a company is to build a major global biopharmaceutical corporation while focusing on the discovery, the development, and the commercialization of products for the treatment of cancer and other severe, immune, inflammatory conditions.
Gilead Sciences
Gilead Sciences, Inc. is a research-based biopharmaceutical company focused on the discovery, development, and commercialization of innovative medicines.
GlaxoSmithKline
GlaxoSmithKline is a science-led global healthcare company with a mission to help people do more, feel better, live longer. We research, manufacture and make available a broad range of medicines, vaccines and consumer healthcare products. Visit our exhibit for information about our products and resources.
Horizon Pharma
Horizon Pharma plc is a biopharmaceutical company focused on improving patients’ lives by identifying, developing, acquiring and commercializing differentiated and accessible medicines that address unmet medical needs. The company markets 11 medicines through its orphan, rheumatology and primary care business units.
Lilly
Lilly is a global healthcare leader that unites caring with discovery to make life better for people around the world. We were founded in 1876 by a man committed to creating high-quality medicines that meet real needs, and today we remain true to that mission. To learn more, visit www.lilly.com.
Novartis
Our mission at Novartis is to discover new ways to improve and extend people’s lives. We use science-based innovation to address some of society’s most challenging healthcare issues and develop breakthrough treatments, and find new ways to deliver them to as many people as possible.
Pfizer
Pfizer Corporate Responsibility believes that all individuals, everywhere, deserve access to quality healthcare and the opportunity to lead healthy lives. We combine traditional philanthropic methods with novel approaches that create an enduring and meaningful impact on public-health systems to facilitate access to healthcare for under-served communities around the world.
Sanofi Genzyme Regeneron
Regeneron and Sanofi Genzyme are committed to investigating new approaches that address unmet medical needs in inflammatory and immunological diseases. Our work is focused in the areas of rare diseases, multiple sclerosis, oncology, and immunology. Each day we continue to advance new therapies, demonstrating our commitment to making a positive impact on the lives of patients around the world.
Diamond Corporate Members
Mallinckrodt Pharmaceuticals
Mallinckrodt Pharmaceuticals is a multibillion dollar specialty pharmaceutical company focused on our mission: Managing Complexity. Improving Lives. We provide medicines to address unmet patient needs, stemming from 150 years of using our unique strengths, experience and expertise to help improve people’s lives.
UCB
At UCB, patients are at the heart of everything we do. Since UCB was established in the U.S. in 1994, the U.S. affiliate of UCB has continuously maintained invaluable programs for patients, healthcare professionals, caregivers and patient communities. Many of the programs we support are noted for their innovative and pioneering work in healthcare.
Silver Corporate Members
Genentech
As the founders of the biotechnology industry, our goal is to use the power of genetic engineering and advanced technologies to make medicines that address unmet medical needs, and help millions of people worldwide.
Ironwood
Ironwood is committed to the art and science of making medicines. Patient needs shape our business. Shareholders shape our success. Employees shape our future. Our discovery and development processes have generated a product that’s approved in the United States, the European Union and a number of other countries, as well as a robust pipeline. We hope to continue earning the right to make medicines and, one step at a time, build an enduring pharmaceutical company that helps patients lead better lives.
Janssen
For more than 30 years, Janssen Biotech, Inc. has delivered on the promise of new treatments and new ways to improve the health of individuals with serious disease. Built upon a rich legacy of innovative “firsts,” Janssen Biotech, Inc. pursues innovative solutions in the therapeutic areas of immunology, oncology, and nephrology. With the same unwavering passion for new challenges, we dedicate ourselves to delivering solutions for these disease states where unmet needs continue to exist.
Sandoz
At Sandoz, we discover new ways to improve and extend people’s lives and pioneer novel approaches to help people around the world access high-quality medicine. We have a long history of innovating to increase access to high-quality, affordable medicines to millions of patients around the world. Sandoz is led by a diverse team with extensive experience in the generic pharmaceutical and biopharmaceutical industry.
Silvergate Pharmaceuticals, Inc.
At Silvergate, we are dedicated to improving the quality, accessibility, and delivery of FDA-approved medications for children. The Silvergate Management Team is focused on filling the unmet medical needs of children by developing and commercializing innovative pediatric medications.
Vectra
Vectra simultaneously measures 12 key biomarkers associated with RA disease activity and combines them into a single score between 1 and 100 (where a lower score indicates less disease activity). By providing an objective and reproducible measure of RA disease activity that can be used alongside existing assessment tools, Vectra helps patients with RA and their healthcare professionals to work together in determining individualized treatment goals.
National Chapter Sponsors
AbbVie
AbbVie is a global, research-based biopharmaceutical company which combines the focus of a leading-edge biotech with the expertise and structure of a long-established pharmaceutical leader. AbbVie is committed to using unique approaches to innovation to develop and market advanced therapies that address some of the world’s most complex and serious diseases.
National Advocacy Sponsors
Bristol-Myers Squibb
Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. We are a differentiated company, led by our unique BioPharma strategy that leverages the reach and resources of a major pharma company paired with the entrepreneurial spirit and agility of a biotech firm.
Pfizer
Pfizer Corporate Responsibility believes that all individuals, everywhere, deserve access to quality healthcare and the opportunity to lead healthy lives. We combine traditional philanthropic methods with novel approaches that create an enduring and meaningful impact on public-health systems to facilitate access to healthcare for under-served communities around the world.
Sanofi Genzyme Regeneron
Regeneron and Sanofi Genzyme are committed to investigating new approaches that address unmet medical needs in inflammatory and immunological diseases. Our work is focused in the areas of rare diseases, multiple sclerosis, oncology, and immunology. Each day we continue to advance new therapies, demonstrating our commitment to making a positive impact on the lives of patients around the world.